Search
for
Sort by
Research 781–810 of 1000+
- Sjögren's Syndrome in Scurvy
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Skin signs in anorexia nervosa
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- THE PREVALENCE OF SKIN DISEASE IN THE GERIATRIC AGE GROUP
- Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study
- Accelerated senescence in skin in a murine model of radiation-induced multi-organ injury
- Skin toxicity of anti‐cancer therapy
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- Cutaneous manifestations of endocrine-metabolic disease and nutritional deficiency in the elderly
- Safety Profile for Microneedling: A Systematic Review
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Dermatologic Problems of Older Women
- Follicular ichthyosis
- Prophylaxis and Management of Skin Toxicities
- Séquelles cutanéomuqueuses et oculaires des SJS et de Lyell
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Zinc and biotin deficiencies after pancreaticoduodenectomy.
- Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence
- Osteosclerosis and periostal new bone formation during indinavir therapy